Ipsen Biopharmaceuticals Inc:企業の戦略的SWOT分析

◆英語タイトル:Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1819
◆発行会社(調査会社):GlobalData
◆発行日:2019年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Ipsen Biopharmaceuticals Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Ipsen Biopharmaceuticals Inc (Ipsen), a subsidiary of Ipsen SA, is a biotechnology company that develops and commercializes pharmaceuticals in the areas of neurology and endocrinology. The company’s product portfolio includes Increlex (mecasermin) injection indicated for the treatment of children suffering from short stature due to severe primary IGFD; Onivyde injection indicated for the treatment of patients with metastatic adenocarcinoma of the pancreas; Somatuline Depot (lanreotide) injection used to treat acromegaly and neuroendocrine tumors; and Dysport (abobotulinumtoxinA) injection indicated for the treatment of adults with cervical dystonia, upper limb spasticity, and pediatric patients with lower limb spasticity. The company partners with biopharmaceutical companies, scientific and clinical communities to develop new therapies against endocrine and metabolic diseases. Ipsen is headquartered in Basking Ridge, New Jersey, the US.

Ipsen Biopharmaceuticals Inc Key Recent Developments

Feb 14,2019: Ipsen delivers strong 2018 results and expects continued sales and profit growth in 2019
Apr 26,2018: Ipsen Reports Strong First Quarter 2018 Sales Growth of 23.1% at Constant Exchange Rates
Feb 21,2018: Arix Bioscience and Ipsen sign a strategic agreement to develop and commercialise innovative therapies
Jan 10,2018: Ipsen appoints Aidan Murphy as Executive Vice-President, Technical Operations

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
Ipsen Biopharmaceuticals Inc – Key Facts
Ipsen Biopharmaceuticals Inc – Key Employees
Ipsen Biopharmaceuticals Inc – Key Employee Biographies
Ipsen Biopharmaceuticals Inc – Major Products and Services
Ipsen Biopharmaceuticals Inc – History
Ipsen Biopharmaceuticals Inc – Company Statement
Ipsen Biopharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Ipsen Biopharmaceuticals Inc – Business Description
Ipsen Biopharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Ipsen Biopharmaceuticals Inc – Strengths
Ipsen Biopharmaceuticals Inc – Weaknesses
Ipsen Biopharmaceuticals Inc – Opportunities
Ipsen Biopharmaceuticals Inc – Threats
Ipsen Biopharmaceuticals Inc – Key Competitors
Section 3 – Company’s Recent Developments
Feb 14, 2019: Ipsen delivers strong 2018 results and expects continued sales and profit growth in 2019
Feb 21, 2018: Arix Bioscience and Ipsen sign a strategic agreement to develop and commercialise innovative therapies
Jan 10, 2018: Ipsen appoints Aidan Murphy as Executive Vice-President, Technical Operations
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Ipsen Biopharmaceuticals Inc, Key Facts
Ipsen Biopharmaceuticals Inc, Key Employees
Ipsen Biopharmaceuticals Inc, Key Employee Biographies
Ipsen Biopharmaceuticals Inc, Major Products and Services
Ipsen Biopharmaceuticals Inc, History
Ipsen Biopharmaceuticals Inc, Subsidiaries
Ipsen Biopharmaceuticals Inc, Key Competitors

★海外企業調査レポート[Ipsen Biopharmaceuticals Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Star Entertainment Group Ltd:企業の戦略・SWOT・財務情報
    The Star Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary The Star Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Habib Metropolitan Bank Limited:企業の戦略・SWOT・財務分析
    Habib Metropolitan Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Habib Metropolitan Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Tidewater Inc (TDW):石油・ガス:M&Aディール及び事業提携情報
    Summary Tidewater Inc (Tidewater) is an an petroleum service company that offers offshore supply vessels and marine support services. The company's services include transport and supply of offshore material; anchor handling, towing and positioning; construction support; well stimulation, FPSO suppor …
  • Dova Pharmaceuticals Inc (DOVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Dova Pharmaceuticals Inc (Dova), formerly PBM AKX Holdings LLC, is a clinical-stage pharmaceutical company that acquires, develops and commercializes therapies for the treatment of orphan diseases. The company’s lead candidate, Avatrombopag (DOPTELET), a novel, oral thrombopoietin receptor a …
  • Sequella Inc-医療機器分野:企業M&A・提携分析
    Summary Sequella Inc (Sequella) is a clinical-stage pharmaceutical company that develops and commercializes small molecule and natural product-based therapeutics for the treatment of infectious diseases. The company’s product pipeline include SQ109, Sutezolid, SQ641 and SQ609; and a novel rapid anti …
  • Catalyst Paper Corporation:企業の戦略的SWOT分析
    Catalyst Paper Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • SRT Marine Systems plc (SRT):企業の財務・戦略的SWOT分析
    SRT Marine Systems plc (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Gebr. Heinemann SE & Co KG:企業の戦略・SWOT・財務分析
    Gebr. Heinemann SE & Co KG - Strategy, SWOT and Corporate Finance Report Summary Gebr. Heinemann SE & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • OncoStem Diagnostics Pvt. Ltd:企業の製品パイプライン分析2018
    Summary OncoStem Diagnostics Pvt Ltd (OncoStem) is a provider of clinical trial solutions. The company develops multimaker prognostic and predictive testing enabling detecting and treating patients affected with cancer. It develops various tests in identifying patterns of repetition in cancer. OncoS …
  • American Dental Partners Inc:企業の戦略的SWOT分析
    American Dental Partners Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Anthem Inc (ANTM)-製薬・医療分野:企業M&A・提携分析
    Summary Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers several managed healthcare related products and related administrative services. It also provides various specialty and insurance products and services including radiology benefit management, dental, life an …
  • Merrimack Pharmaceuticals Inc (MACK):製薬・医療:M&Aディール及び事業提携情報
    Summary Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company’s marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (mark …
  • Terumo Cardiovascular Systems Corporation:医療機器:M&Aディール及び事業提携情報
    Summary Terumo Cardiovascular Systems Corporation (TCSC), a subsidiary of Terumo Corporation, is a provider of medical equipment and devices for cardiac and vascular surgeries. It produces hardware products including heart-lung machines and intra-operative monitoring systems for cardiac surgeries. I …
  • Penn National Gaming Inc:企業の戦略・SWOT・財務分析
    Penn National Gaming Inc - Strategy, SWOT and Corporate Finance Report Summary Penn National Gaming Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Skandinaviska Enskilda Banken AB:企業のM&A・事業提携・投資動向
    Skandinaviska Enskilda Banken AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Skandinaviska Enskilda Banken AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Sunrise Coal LLC:企業の戦略・SWOT・財務分析
    Sunrise Coal LLC - Strategy, SWOT and Corporate Finance Report Summary Sunrise Coal LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Inivata Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Inivata Ltd (Inivata) is a cancer genomics company that harnesses liquid biopsy platform to enhance personalized healthcare in oncology. The company’s product portfolio includes InVisionFirst – Lung, which offers advanced sequencing technology to detect copy number variants, single nucleotid …
  • Teledyne Technologies Incorporated (TDY):企業の財務・戦略的SWOT分析
    Teledyne Technologies Incorporated (TDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Tampa Electric Co:企業の発電所・SWOT分析2018
    Tampa Electric Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Firestone Diamonds plc:企業の戦略・SWOT・財務情報
    Firestone Diamonds plc - Strategy, SWOT and Corporate Finance Report Summary Firestone Diamonds plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆